Health ❯ Healthcare ❯ Pharmaceuticals

Cancer Treatment

Breast Cancer Immunotherapy Clinical Trials Multiple Myeloma Bladder Cancer Lung Cancer Small Cell Lung Cancer Targeted Therapy Pancreatic Cancer Drug Development

AstraZeneca Beats Q2 Estimates and Reaffirms 2026 Guidance

The results show near-term commercial strength that will test investor confidence in the company’s pipeline after recent late-stage trial failures.

FDA Approves Revtorpyk for HER2‑Low Breast Cancer but Launch and Safety Questions Loom

AstraZeneca Licenses Global Rights to Zegfrovy From Dizal

FDA Clears Wearable Injector Form of Sanofi’s Multiple Myeloma Drug

Lilly Launches Tanstrive as First Selective RET Inhibitor Now Available in India

Anvisa Approves Inluriyo as Oral Treatment for ER‑Positive, HER2‑Negative, ESR1‑Mutant Advanced Breast Cancer

Pfizer Lung Cancer Drug Fails to Improve Survival in Late‑Stage Trial

Government Raises Price Caps on Cisplatin and Carboplatin by 50%

GSK to Buy Nuvalent for $10.6 Billion to Bolster Lung‑Cancer Pipeline

EU Clears Sanofi’s Sarclisa for Subcutaneous Use With Portable Injector

New Oral Drug Nearly Doubles Survival for Treated Metastatic Pancreatic Cancer

India Faces Nationwide Shortage of Key Chemotherapy Drugs Cisplatin and Carboplatin

TheraNyM Biologics Opens ₹1,200 Crore Biologics Plant Near Hyderabad

Ivonescimab Extends Survival in China Phase 3 Trial for Squamous Lung Cancer

Study Finds Post-Diagnosis GLP-1 Use Linked to Lower Risk of Cancer Progression

Sacituzumab Tirumotecan With Keytruda Improves Progression-Free Survival in China Phase 3 Lung Cancer Trial

EMA Recommends Etcamah for ESR1‑Mutant Advanced Breast Cancer

FDA Accepts ImmunityBio Filing to Expand ANKTIVA Use in Bladder Cancer

Roche Launches 7-Minute Under-the-Skin Lung Cancer Shot in India

FDA Grants Accelerated Approval to First BCL2 Drug for Relapsed Mantle Cell Lymphoma